Study on the clinical effects of neoadjuvant chemoradiotherapy combined with surgery applied to colorectal cancer patients.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002772

Enrollment

Unknown

Registered

2012-12-04

Start date

2012-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

A:neoadjuvant chemoradiotherapy combined with surgery

Eligibility

Sex/Gender

Male

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with colorectal cancer by preoperative colonoscopy and postoperative pathologic examination; 2. Accepted a surgery; 3. First attacked.

Exclusion criteria

Exclusion criteria: 1. Missing data more than 20%; 2. Severe hepatorenal function failure; 3. Immune dysfunction , such as HIVaplastic anemialeukemiaetc; 4. Complicated with disease causing skin changes, such as eczema urticarian dermatitis, SLE etc.; 5. Taking medicine which adverse effects similar with chemotherapy drugs, such as hormone immunosuppressive drugs, etc.; 6. Received chemotherapy or radiotherapy before this hospitalization; 7. TNM stage I; 8. Received chemotherapy or radiotherapy after surgery in one month; 9. Die after surgery in one month.

Design outcomes

Primary

Measure	Time frame
postoperative rehabilitation indicators;chemoradiotherapy adverse reactions indicator;	—

Contacts

Public ContactLi Ka

likalika127127@163.com+86 18980601488

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026